CME Group Inc - Ordinary Shares - Class A

CME Group Inc - Ordinary Shares - Class A

CME

Get informed when a big investor buys or sells

+ Follow
Market Cap$88.8B
Close$

Compare to Similar Companies

P/E RatioDividendsReturn on EquityPrice-to-SalesDebt-to-Equity
CME Group Inc - Ordinary Shares - Class ACME Group Inc - Ordinary Shares - Class A20.84.59%16%13.80.1

Earnings Call Q2 2026

July 22, 2026 - AI Summary

Strong Q2 financial/performance momentum (good): - Revenue: >$1.7B, +1% YoY and a record for Q2 (2nd-highest all-time quarterly behind Q1’26). - Market data revenue: +$238M, +20% YoY, with 33 consecutive quarters of YoY market data growth and 8 consecutive quarters of record. - Adjusted profitability: Adjusted operating income ~$1.2B; adjusted operating margin 69.5%. - EPS: Adjusted diluted EPS ~$2.99, +1% vs Q2’25 (adjusted net income margin 63.4%). - Capital returned: $1.2B to shareholders in the quarter ($468M dividends + $695M share repurchases).
Volumes/open interest & capital-efficiency highlights (good, with clear demand signal): - Q2 average daily volume (ADV): 29.8M contracts = 2nd-highest Q2 in CME history, within 1% of last year’s record Q2 (notably May/June strong after a tougher April comparison). - Open interest: +8% YoY and +16% since start of year. - Capital efficiency claim: CME delivered record customer margin savings—> $95B per day on average. - H1’26 and near-term read-through: H1 volume 10% ahead of last year; revenue +8%, adjusted EPS +10%. July-to-date volume +18% YoY.
Perpetual futures debate: CME position is “no demand from core customers” (bad/surprising but clarifying): - Management argued perpetual futures aren’t appropriate for institutional hedging (CME claims 94% of volume is institutional in H1’26). - Claims that perpetuals: rely on frequent funding-rate adjustments, have high leverage/auto-liquidations, provide limited protections, and are far more expensive when considering transaction fee + daily funding cost vs CME futures. - Customer-demand takeaway (key investor signal): CEO said they’re hearing no real institutional demand and offered a specific example from a major energy participant saying they do not want perpetuals due to risk-management incompatibility.

Exclusive for Stockcircle Pro members

Sign upSign Up
$320.22

Target Price by Analysts

28.5% upsideCME Group Target Price DetailsTarget Price
$447.58

Current Fair Value

79.6% upside

Undervalued by 79.6% based on the discounted cash flow analysis.

Share Statistics

Market cap$88.80 Billion
Enterprise Value$89.83 Billion
Dividend Yield$11.25 (4.59%)
Earnings per Share$11.18
Beta0.28
Outstanding Shares359,318,000

Return

Return on Equity15.94%ROE
Return on Assets2.10%
Return on Invested Capital14.51%

Valuation & Multiples

P/E Ratio20.77P/E Ratio
PEG93.33PEG
Price to Sales13.85Price to Sales
Price to Book Ratio3.37Price to Book Ratio
Enterprise Value to Revenue13.29
Enterprise Value to EBIT17.2
Enterprise Value to Net Income21
Total Debt to Enterprise0.04
Debt to Equity0.13Debt to Equity

Revenue Sources

No data

Insider Trades

Last Earnings Call

Report Date
July 22, 2026
EPS Estimate
$2.91
Average shareholder expectation
Revenue Estimate
$1.68 B
Average shareholder expectation

Next Earnings Call

Expected Date
October 28, 2026
EPS Estimate
$2.93
Average shareholder expectation
Revenue Estimate
$1.70 B
Average shareholder expectation

Institutional Put/Call Ratio

Market sentiment based on institutional option activity.

Put/Call Ratio0.0000▼ 109.34%
Total Calls-▼ 100.00%
Total Puts-▼ 100.00%

Institutional Ownership

Holdings and activity of institutional investors.

Ownership %3.03%▼ 86.28%
Total Invested$2.25B▼ 97.63%
Investors Holding310▼ 1541.00%

ESG Score

No data

About CME Group Inc

CEO: Terrence Duffy

Relevant Senate Committees

Joint Committee on Taxation

This committee provides official revenue estimates and technical analysis for all tax legislation, directly influencing corporate tax structures and fiscal policy that profoundly affect CME Group's financial health and strategic decisions.

Finance

As the most powerful economic committee controlling taxation and trade, it directly influences corporate tax policy, which impacts CME Group's profitability and valuation, and trade policies that affect global markets and commodity flows traded on its exchanges.

Agriculture, Nutrition, and Forestry

This committee directly oversees the CFTC (Commodity Futures Trading Commission), which is the primary regulator for CME Group's commodity futures and derivatives markets. Its role in defining cryptocurrencies as digital commodities is also highly relevant to CME's crypto offerings.

Banking, Housing, and Urban Affairs

This committee directly regulates the entire financial system, including the SEC (which oversees securities exchanges) and critically impacts cryptocurrency regulation, a growing area for CME Group through its futures products. Its decisions on bank capital requirements and financial market oversight directly affect CME's business environment.

Energy and Natural Resources

This committee directly oversees national energy policy, public lands, and the Department of Energy, which directly impacts the supply, demand, and valuation of oil, gas, and other natural resources traded extensively on CME Group's commodity exchanges.